We encourage you to review this Privacy Notice often to stay informed of how we may process your information. The securities referred to herein will not be registered under the U.S. Securities Act of 1933, as
Avoid Counterfeits, Bayers role in
8+ years experience in a clinical operations role in biopharmaceutical industry with at least 5 years direct experience running oncology Ph1 clinical trials. NextPoint Therapeutics Raises $80M in Series B Financing Jan 10, 2023| staff reporter Save for later NEW YORK - NextPoint Therapeutics said on Tuesday that it has raised $80 million in Series B financing, which it will put toward advancing its precision oncology drugs targeting the HHLA2 pathway. Republic, Dominican
Drs. Innovation, Bayer
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. of
offer within the meaning of Regulation (EU) 2017/1129. Degree in nursing, life sciences or a related discipline preferred. We have no control over, do not review, and are not responsible for Third-Party Sites, their content, or any goods or services available through the Third-Party Sites. Oricell has applied for over 100 invention patents (including 6 PCT), with 10 already granted. language options. Germany
The successful candidate will have a deep scientific knowledge and experience with oncology and immuno-oncology targets, biomarkers and animal models. jurisdictions, only certain categories of person may be allowed to view such materials. Please note, however, we cannot fully eliminate security risks associated with the storage and transmission of Personal Data. We are currently looking to add a Vice President Translational Science to our fast moving, roll-up your sleeves team environment. Safety, Climate
Position, Position
Where we are processing your Personal Data, subject to applicable law, you also have the right to: To exercise your rights, you may contact us as atinfo@nextpointtx.com. for
Our use or disclosure of de-identified or anonymized data is not subject to this Privacy Notice. For more information, go to leaps.bayer.com. The Bayer brand stands for trust, reliability and quality throughout the world. for
NextPoint Therapeutics has announced an $80 million Series B funding round to move two lead precision immuno-oncology programs into the clinic. Services & Downloads, AGM
Learn more about
To access
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Fakes, Background
being referred to as relevant persons). sufficient information on the terms of the offer and any securities to be offered so as to enable an
status, Contact
Expertise, Our
This can include cookies, web beacons and similar technologies as described above. Please be advised that you may not be able to opt-out of receiving certain service or transactional messages from us, including legal notices and certain communications related to the provision of the Site. Statements, Reports
- NextPoint Therapeutics, a Cambridge, Mass.-based immuno-oncology development company, raised $80 million in Series B funding. Phone: +49 30 468 1111, Alfred-Nobel-Str. Features
If you are located outside of the United States, the transfer of Personal Data is necessary to provide you with the requested information and Site and/or to perform any requested transaction. Existing investors that took part in the financing include MPM Capital Management, Dana-Farber Cancer Institutes Binney Street Capital and NextPoint founder Gordon Freeman, PhD. Stewardship, Pharmaceuticals
Rica, Czech
Bayer Global
materials. NEXTPOINT THERAPEUTICS, INC. Company Number 7059407 Incorporation Date 17 September 2018 (over 4 years ago) Company Type Corporation Jurisdiction Delaware (US) Agent Name THE CORPORATION TRUST COMPANY Agent Address CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, New Castle, DE, 19801 Directors / Officers THE CORPORATION TRUST COMPANY, agent Conduct, Product
Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Related Persons. Interview, Check
http://tools.google.com/dlpage/gaoptout?hl=us, http://www.google.com/analytics/terms/us.html, https://optout.networkadvertising.org/?c=1, Personal identifiers such as name, date of birth, email address, IP address, account name, online identifier, social security number, license number or other similar identifiers, You, your computer and mobile devices when you access our Site, To allow you access to our Site and to provide you with services, such as responding to questions you may have. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. an offer to sell or the solicitation of an offer to buy securities issued by Bayer. Bhatt RS, Berjis A, Konge JC, et al. 6. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. ////// Science for a better
The following materials are not directed at or to be accessed by persons located in the United
The investment portfolio includes more than 50 companies. and may not be offered or sold in the United States, except pursuant to an exemption from, or in a
NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. If you breach any provision of these Terms, any license you have obtained will be automatically rescinded and terminated. Use the Website for any purpose that is unlawful or prohibited by these Terms. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Our scientific successes are intended to help improve peoples lives. Previous study start-up and clinical monitoring experience desired. Submit material that is intentionally false, defamatory, unlawfully threatening or unlawfully harassing. Independently design, execute and manage translational research activities from discovery through clinical development, Develop and implement research and clinical-level assays, along with data analysis, interpretation, and report generation, Work closely with the research and preclinical team to identify novel biomarkers and translate to the clinical setting, Integrate biomarker and clinical data to guide patient stratification, Manage CROs responsible for the generation of both exploratory and clinical biomarker data, Contribute to clinical documents such as, INDs, IBs, regulatory submissions, laboratory manuals and clinical protocols, Function as a scientific thought leader inside the company for cutting edge biomarker approaches. available in electronic format on this webpage does not constitute an offer to sell or the
Interested in finding out more?Please send your resume and cover letter to HR@nextpointtx.com. | Learn more about Anne Koehler, PhD's . land, water and energy. He is currently CEO of portfolio company NextPoint Therapeutics and is also a board member of portfolio company iTeos Therapeutics (NASDAQ: ITOS). Bayer is an innovation company with a more than 150-year history. an offer to the public of the securities has not been made and will not be made in such Relevant
Tool, Innovation
Distances, Work
Presentations, Annual
Importantly, HHLA2 is independent of PD-L1 and is often most strongly expressed in PD-L1-negative cancers. in the United States absent registration or an applicable exemption from the registration
OurPrivacy Noticeexplains how we treat information that you provide to us through the Website and our Terms govern your use of our Website and Content. the securities prospectus. You may only make a verifiable consumer request for access or data portability twice within a 12-month period. This monoclonal antibody technology and related intellectual property has been licensed to NextPoint Therapeutics, which is developing a pipeline of therapeutic antibody candidates targeting KIR3DL3 and HHLA2. An
on
Kaiser-Wilhelm-Allee 1
We may collect Person Information from you in a variety of ways: If you wish to exercise your rights under California law, please see the Right to Access and Control Your Personal Information Under the European Union Data Protection Regulation (GDPR) and CCPA section below for information on how to contact us to exercise your rights. &
Life & Challenges, Reputation
+49 2173 380. NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. We are currently looking to add a highly motivated Research Associate to our fast moving, roll-up your sleeves team environment. We may update this Privacy Notice from time to time. For the purposes of this provision, the expression an offer to the public in relation to any
Meeting & Agenda, Stockholders'
Prospectus Directive), as permitted under the Prospectus Directive, or. Fraudulent Brands, Commitment to
these pages, please confirm that you are a medical journalist and that you would like to accredit to
Arab Emirates, United
About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Please note that if you are visiting the Site from outside of the United States, your information may be transferred to, stored, and/or processed in the US. If you become aware that an individual under 13 years of age has provided us with Personal Data without parental consent, please contact us atinfo@nextpointtx.com. For more information. For example, you will not use the Website to violate any law, statute or regulation (including, without limitation, those governing export control, consumer protection, unfair competition, anti-discrimination or false advertising). With our distinctive knowledge of people, animals and plants,
Supply Chain Management Trainee Program, International
Our innovative approach integrates foundational. The Bayer brand stands for trust, reliability and quality throughout the world. In other
Bayers leadership in agriculture provides tailored solutions
COVID19 vaccination required for onsite work; Exemptions for religious or medical reasons should reach out to HR for accommodations. A cookie is a small text file that a web server stores in browser software. Sanofi Ventures is the corporate venture capital arm of Sanofi. Publications, Job
The additional money will help the fund make more investments globally, Sanofi Ventures said Wednesday. As described in detail below, we may collect certain Personal Data from or about you in connection with your use of, or your submissions to, the Site. join
For more information, go to, Leaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. NextPoint Therapeutics, founded in 2018, reeled in $80 million in equity from 13 investors last month, according to an SEC filing from December. About. We are thrilled to support NextPoint, an exciting addition to our oncology portfolio, as it works to redefine the treatment landscape of immuno-oncology.. You are not required to provide all Personal Data identified in this Privacy Notice in order to use the Site; however, if you do not provide the Personal Data requested, we may be unable to provide some or all of the Site to you. 2015 May 15;21(10):2359-66. I have read and understood the disclaimer set out above. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. You can use our locations menu to find Bayer country websites and
States by use of the mails or by any means or instrumentality (including, without limitation,
Among these areas are oncology, immunology, rare diseases, vaccines, potential cures in other core areas of Sanofis business footprint, and digital health solutions. He is a co-founder and scientific advisor at NextPoint Therapeutics, an immuno-oncology checkpoint inhibitor company founded by MPM capital that has raised over $100 million in series A and B funding. Use the Website to artificially generate traffic or page links to a website or for any other purpose not expressly allowed under these Terms. public offer of the securities in the United States. Innovations, Redefining
Bayer Global
expression Prospectus Directive includes any relevant implementing measure in each Relevant Member
1 Wei Y, Ren X, Galbo PM Jr, et al. Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Sweetwater, TX (79556) Today. Committed to developing novel immunotherapies. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. As part of the financing, Rakhshita Dhar, Senior Director of Venture Investments Health at Leaps by Bayer, and Paulina Hill, Partner at Sanofi Ventures, will join the NextPoint Board of Directors. An investment decision regarding the securities referred to herein should only
Making press
New Talent, Bayer 04
indirectly, in or into the United States by use of the mails or by any means or instrumentality
2003/71/EC, and any amendments thereto (the Prospectus Directive)(each a Relevant Member State),
Investing in a stronger future - for our shareholders, and
There will be no
NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in
NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Officer, Associate Director/Director, Clinical Operations, You should also understand that our Code of Conduct is based in many instances on principles of applicable law. e-mail, facsimile transmission, telephone and the internet) of interstate or foreign commerce, or of
13353 Berlin
They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. About Leaps by BayerLeaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the
R&D expenses before special items amounted to 5.3 billion euros. find Bayer country websites and
25. Trainee Program for Financial Management, Internal
In the United Kingdom the following materials are only directed at (i) investment professionals
Winds SE at 15 to 25 mph. Career Worldwide, Data
It is committed to developing tumor cellular immunotherapeutics through its own innovative technology platforms. solicitation of an offer to buy securities issued by Bayer. Audit, International
for a hungry planet, Bayer
Use the Website in a manner that could disable, overburden or impair the Website or interfere with any other partys use and enjoyment of the Website, such as through sending spam.. "We've been profitable and self-funded for 20 years. investment decision regarding the securities referred to herein should only be made on the basis
For more information, go to leaps.bayer.com. solicitation to purchase or subscribe for securities in the United States, Australia, Canada or
us, Talent
Seek to obtain access to any materials or information through hacking, data harvesting or through other means we have not intentionally made available to you through the Website. Previously, she worked at the Dana-Farber Cancer Institute, where she was director of the Center for Cancer Therapeutic Innovation. for
Headquarters, Costa
RIGHT TO ACCESS AND CONTROL YOUR PERSONAL INFORMATION UNDER THE EUROPEAN UNION DATA PROTECTION REGULATION (GDPR) AND CALIFORNIA CONSUMER PRIVACY ACT (CCPA). in any other circumstances falling within Article 3(2) of the Prospectus Directive. Drive the clinical biomarker function to identify indications, support patient stratification and to inform on mechanism of action; develop, qualify, and execute biomarker assays with the most appropriate technical platforms to advance and support immune-oncology therapeutics to the clinic. PLEASE READ THIS DOCUMENT CAREFULLY BEFORE YOU ACCESS OR USE THE WEBSITE OR CONTENT. Community, Bayer
Protected classification characteristics under California or federal law such as age, gender, gender identity, gender expression, health information, education, We do not generally collect this information, Commercial information, such a Services provided, your interaction with our Site and Services, To allow you access to our Services, to provide you with Services, to respond to questions you may have. Statements, Questions
Rankings, Vision &
As a leader in healthcare, Bayer provides innovative solutions designed to prevent, alleviate and treat diseases. Tuesday's. Angela Poppe Ries, MD, was named chief medical officer of VyncaCare, a home healthcare company for patients living with serious illness. HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T cell function. This website is intended to provide information to an international audience outside the USA and UK. Stories, Annual
Read more about our economic, ecological and social challenges and opportunities. Phone: +49 214 30 1, Mllerstrae 178
at the Forefront, Consumer Health
These factors include those discussed in Bayers public reports which are available on the Bayer website at www.bayer.com. in Pharmaceutical Science and Technology and I have a passion for medical affairs, pharmaceutical sciences, project management, and business development.